[LOUISVILLE, Ky.] Jan. 2, 2026—Induction Therapies announces the launch of Youth XO +PDRN Serum, a recovery serum that allows clinicians a new way of integrating PDRN into modern treatment protocols.
PDRN was all the rage in 2025, made famous by Kim Kardashian and the salaciously named "salmon sperm facial." Traditionally, PDRN has been limited to injectable or in-office applications derived from animal sources, often restricting its scalability and patient accessibility. Since its rise to popularity, though, the industry has experimented with moving past the fish of it all, sourcing PDRN from plants like ginseng and rice, for a more sustainable alternative that's extra appealing to vegan consumers.
Youth XO +PDRN Serum
Induction Therapies' formulation marks a notable shift in the category through the use of V-PDRN (vegan polydeoxyribonucleotide) paired with plant-derived exosomes and THD ascorbate, offering a more stable, accessible and retail-ready approach to regenerative skin care.
“We’re seeing growing curiosity around PDRN among dermatology professionals, but also hesitation due to sourcing, stability and patient alignment,” says Justin Inscoe, clinical trainer at Induction Therapies. “Youth XO was developed to bridge that gap—offering a clinically intelligent, plant-based approach that supports recovery while opening the door to retail and private-label opportunities.”
A Synergistic System for Skin Recovery
Youth XO pairs V-PDRN with plant exosomes, which act as biological messengers supporting cellular communication and recovery pathways, and THD ascorbate, a lipid-soluble form of vitamin C known for stability and enhanced dermal compatibility.
The result is a formula suited for:
- Post-procedure support
- Sensitized or barrier-impaired skin
- Transitional care between in-office treatments
- Daily use as a recovery-focused maintenance serum
An Entry Point for PDRN
Youth XO is designed not only as a treatment adjunct, but as a strategic on-ramp for providers exploring PDRN-based therapies. As part of Induction Therapies’ private-label program, Youth XO +PDRN also provides practices the opportunity to extend their clinical philosophy into a branded, patient-facing product—bridging in-office treatment and at-home care with consistency and control.
